ConductScience.org, home

Paper19904584

Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.

de Winter BC and 5 others. J Pharmacokinet Pharmacodyn, 2009. Cited by 81 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients. Papers, record 19904584. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19904584

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
PubMed
Journal
J Pharmacokinet Pharmacodyn
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
81
iCite
Relative citation ratio, by iCite
3.17
iCite
Revised in PubMed
2025-10-22
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Winter BCBrenda C M
2van Gelder TTeun
3Sombogaard FFerdi
4Shaw LMLeslie M
5van Hest RMReinier M
6Mathot RARon A A

Source PubMed

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucuronidesMajor topic
Immunosuppressive AgentsMajor topic
KidneyMajor topic
Kidney TransplantationMajor topic
Models, BiologicalMajor topic
Mycophenolic AcidMajor topic
Adult
Aged
Area Under Curve
Biotransformation
Computer Simulation
Creatinine
Cyclosporine
Drug Interactions
Drug Therapy, Combination
Enterohepatic Circulation
Female
Humans
Male
Middle Aged
Protein Binding
Randomized Controlled Trials as Topic
Reproducibility of Results
Serum Albumin
Tacrolimus
Young Adult

Source PubMed

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19,871,432The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.Clin Pharmacol Ther1998https://conductscience.org/library/papers/9871432PubMed
219,691,368Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.Clin Pharmacokinet2009https://conductscience.org/library/papers/19691368PubMed
311,856,782The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy.J Am Soc Nephrol2002https://conductscience.org/library/papers/11856782PubMed
416,628,123Therapeutic drug monitoring of mycophenolate mofetil in transplantation.Ther Drug Monit2006https://conductscience.org/library/papers/16628123PubMed
518,442,296Trends in kidney transplantation over the past decade.Drugs2008https://conductscience.org/library/papers/18442296PubMed
625,156Diseases and drug protein binding.Clin Pharmacokinet1978https://conductscience.org/library/papers/25156PubMed
79,549,665Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function.J Clin Pharmacol1998https://conductscience.org/library/papers/9549665PubMed
88,634,753Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma.J Chromatogr B Biomed Appl1996https://conductscience.org/library/papers/8634753PubMed
915,752,372Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.Br J Clin Pharmacol2005https://conductscience.org/library/papers/15752372PubMed
1015,196,064Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation.Am J Transplant2004https://conductscience.org/library/papers/15196064PubMed
1117,700,162The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.Transplantation2007https://conductscience.org/library/papers/17700162PubMed
1211,907,485Changes in plasma protein binding have little clinical relevance.Clin Pharmacol Ther2002https://conductscience.org/library/papers/11907485PubMed
1316,353,930A new equivalence based metric for predictive check to qualify mixed-effects models.AAPS J2005https://conductscience.org/library/papers/16353930PubMed
1410,684,356Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.Pediatr Nephrol2000https://conductscience.org/library/papers/10684356PubMed
1511,736,871The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes.Br J Clin Pharmacol2001https://conductscience.org/library/papers/11736871PubMed
1616,132,354Mechanism-based pharmacokinetic-pharmacodynamic modeling-a new classification of biomarkers.Pharm Res2005https://conductscience.org/library/papers/16132354PubMed
1719,363,460Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease.Ther Drug Monit2009https://conductscience.org/library/papers/19363460PubMed
1815,816,878Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.Am J Transplant2005https://conductscience.org/library/papers/15816878PubMed
1910,519,445
Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Ther Drug Monit1999https://conductscience.org/library/papers/10519445PubMed
2012,657,908Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?Ther Drug Monit2003https://conductscience.org/library/papers/12657908PubMed

See all 42 references

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.

PMIDTitleJournalYearIn PapersSource
42,797,280Pre-Analytical Stability of Mycophenolic Acid and Its Glucuronide in Saliva Samples Stored in Cotton SalivetteĀ® Devices Before Centrifugation.Pharmaceutics2026https://conductscience.org/library/papers/42797280PubMed
42,580,761Free mycophenolic acid exposure for therapeutic drug monitoring in paediatric lupus nephritis: associations with treatment response and haematologic toxicity.Lupus Sci Med2026https://conductscience.org/library/papers/42580761PubMed
42,536,285Population pharmacokinetics of total and free mycophenolic acid in plasma in paediatric patients with nephrotic syndrome including salivary concentrations and the pharmacodynamics.Pharmacol Rep2026https://conductscience.org/library/papers/42536285PubMed
41,874,950Population Pharmacokinetic Modelling of Unbound Mycophenolic Acid and its Glucuronide in Adult Kidney Transplant Recipients in Early Post-Transplant.Clin Pharmacokinet2026https://conductscience.org/library/papers/41874950PubMed
41,725,328Semi-Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/41725328PubMed
41,304,805Does CytoSorb Interfere with Immunosuppression? A Pharmacokinetic and Functional Evaluation.Pharmaceutics2025https://conductscience.org/library/papers/41304805PubMed
40,900,829Published population pharmacokinetic models of mycophenolate sodium: a systematic review and external evaluation in a Chinese sample of renal transplant recipients.Front Pharmacol2025https://conductscience.org/library/papers/40900829PubMed
40,873,215Biopharmaceutical Factors Involved in the Disposition of Mycophenolic Acid: A Comprehensive Review of ADME Properties and Their Potential Impact on Mycophenolic Acid Plasma Exposure.Curr Drug Metab2025https://conductscience.org/library/papers/40873215PubMed
39,852,117Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients.Curr Issues Mol Biol2024https://conductscience.org/library/papers/39852117PubMed
39,629,510Population pharmacokinetic analysis identifies an absorption process model for mycophenolic acid in patients with renal transplant.Clin Transl Sci2024https://conductscience.org/library/papers/39629510PubMed
39,611,692In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation setting.Pharmacol Res Perspect2024https://conductscience.org/library/papers/39611692PubMed
39,204,389Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation.Pharmaceutics2024https://conductscience.org/library/papers/39204389PubMed
38,117,412Managing Lupus Nephritis in Children and Adolescents.Paediatr Drugs2024https://conductscience.org/library/papers/38117412PubMed
38,036,834Quantification of Mycophenolic Acid in Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).Methods Mol Biol2024https://conductscience.org/library/papers/38036834PubMed
37,493,886Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling.Clin Pharmacokinet2023https://conductscience.org/library/papers/37493886PubMed
37,147,510Therapeutic drug monitoring in childhood idiopathic nephrotic syndrome: a state of the art review.Pediatr Nephrol2024https://conductscience.org/library/papers/37147510PubMed
36,440,680Utility of salivary mycophenolic acid concentration monitoring: Modeling and Monte Carlo validation approach.Pharmacol Res Perspect2022https://conductscience.org/library/papers/36440680PubMed
34,779,909Serum albumin level is associated with mycophenolic acid concentration in children with idiopathic nephrotic syndrome.Eur J Pediatr2022https://conductscience.org/library/papers/34779909PubMed
33,951,752Impact of study design and statistical model in pharmacogenetic studies with gene-treatment interaction.CPT Pharmacometrics Syst Pharmacol2021https://conductscience.org/library/papers/33951752PubMed
33,062,842Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient-No Intervention Actually Needed.Transplant Direct2020https://conductscience.org/library/papers/33062842PubMed

See all 47 cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCC21,244PubTator's text mininghttps://conductscience.org/library/genes/1244NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CRCL261,727PubTator's text mininghttps://conductscience.org/library/genes/261727NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19904584

GET https://conductscience.org/api/papers/v1/19904584/references?page=2